Search

Respimat re-usable wins Pharmapack Eco-Design Award

The Respimat® re-usable inhaler device has won the 2020 Pharmapack Eco-Design Award. An enhanced version of the Respimat® soft mist inhaler, Respimat® re-usable has a lower environmental impact and is easy for patients to use.

Sustainable medicines that help minimize environmental impact

How we collaborate with renowned experts to lead the way in reducing solvent waste, as part of our efforts to embed sustainability into our core business.

founding-member-of-QUTAC

Together, the members of this newly founded consortium want to explore industrial applications for quantum computing

The first liquid solution for hypertension in cats

Boehringer Ingelheim launches Semintra® 10 mg/ml Oral Solution in selected European countries for the treatment of feline hypertension.

Launch of BVDzero scholarship for veterinary students

Launch of BVDzero scholarship for veterinary students globally

About Office Hours

Boehringer Ingelheim Office Hours mentors early-stage life-science companies providing access to expertise, an industry perspective and feedback.

Flood-disaster-in-Germany-donation-from-Boehringer-Ingelheim

Boehringer Ingelheim increases donation for emergency flood relief to EUR 1 million

additional-investment-in-Lyon-Jonage

Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France

Partnership WHO Foundation mental health

Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention

New vaccine against Bovine Respiratory Disease

Boehringer Ingelheim’s Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against Bovine Respiratory Disease.

New production center for Veterinary Public Health

Boehringer Ingelheim invests more than €200 million to establish a strategic production center for Veterinary Public Health in Lyon, France.

Survey with Ipsos to gain insights human-animal bond

Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.

2021 ABCD Young Scientist Award feline health

Young veterinary researchers Julia Klaus and Dr Yasmin Parr receive award for their work into feline SARS-CoV-2 infections and feline leukaemia virus.

EMPRISE-interim-analysis

Interim analysis from EMPRISE real-world study shows decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists

World Rabies Day: BI fights rabies misconceptions

Boehringer Ingelheim joins efforts to fight rabies under this year’s theme for World Rabies Day to raise awareness of the disease and its prevention.

Boehringer Ingelheim collaborates with the Broad Institute

Boehringer Ingelheim and researchers at the Broad Institute of MIT and Harvard are collaborating to tackle the unmet needs of people living with mental health conditions.

IL-11 inhibitor antibody clinical development launched

Boehringer Ingelheim has launched clinical development of its first-in-class IL-11 inhibitor antibody as a fibrotic disease treatment

Global mobility

We are a global company with a global outlook. We welcome the breadth of perspective that international experience brings to our teams.

Partnership Boehringer Ingelheim Lifebit health data

Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data

BI Focuses COVID-19 Clinical Research on Alteplase

BI focuses its COVID-19 therapy research on the development of alteplase as a potential treatment for COVID-19 patients with severe breathing problems

Data Science

Revolutionizing research and development with data driven insights

Joint venture to fight Antimicrobial Resistance

Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Empowering smallholder farmers

The LastMile initiative improves health equity in remote areas of Africa, increasing access to animal health resources for underserved farming communities.

Award winning employer

Boehringer Ingelheim focuses on the wellbeing of its employees – and is therefore also a "Global Top Employer 2023".

Groundbeaking of vaccine production center in France

Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers